A systematic review of the effects of maternal obesity on neonatal outcomes in women with gestational diabetes
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
Photo Credit: Baldwin Publishing Staff Photographer 50 mins Loaded with eggs, vegetables, and Mediterranean-inspired flavors, this breakfast casserole offers plenty of protein along with colorful produce
These peptides are broken down by stomach acid and digestive enzymes before they reach the bloodstream, which negatively impacts the amount your body can absorb
Biol Pharm Bull
The requirements typically include several factors that your doctor must document clearly
